![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Everzinc St-hyacinthe Ca, based in Belgium, is a pharmaceutical company.
One of their significant offerings is Zinc oxide, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2017-015 - Rev 00
This Chemical Type CEP, issued on July 31, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 252 associated with this CEP further emphasizes